Open AccessUpdates on the Diagnosis and Management of Hepatocellular Carcinoma
Author(s) -
Aimun Raees,
Muhammad Kamran,
Hasan Özkan,
Wasim Jafri
Publication year - 2021
Publication title -
euroasian journal of hepato-gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 2231-5128
pISSN - 2231-5047
DOI - 10.5005/jp-journals-10018-1335
Subject(s) - medicine , hepatocellular carcinoma , sorafenib , liver transplantation , cirrhosis , disease , intensive care medicine , radiation therapy , etiology , transplantation
Globally, the incidence, as well as mortality, related to hepatocellular carcinoma (HCC) is on the rise, owing to relatively few curative options. Underlying cirrhosis is the most common etiology leading to HCC, but risk factors of cirrhosis show great regional variability. Over the years, there has been a steady development in the diagnostic and therapeutic modalities of HCC, including the availability of a wide range of systemic chemotherapeutic agents. We aim to review the recent advancements in the diagnostic and therapeutic strategies for HCC.